ImmuKnow+

Volume 2, Issue 2

Justin Balko & Brandie Taylor - VI4 Scientists Doing Things

Justin Balko & Brandie Taylor
VI4 Scientists Doing Things

Dr. Justin Balko and graduate student Brandie Taylor challenged each other to a pipette race while we asked them some questions about their research....... Click to watch!


Dawn Necomb & Nowrin Chowdhury - VI4 Scientists Doing Things

Dawn Necomb & Nowrin Chowdhury
VI4 Scientists Doing Things

Dr. Dawn Newcomb and graduate student Nowrin Chowdhury challenged each other to a game of Uno while we asked them some questions about their research...... Click to watch!


Justin Balko & Brandie Taylor - VI4 Scientists Doing Things

Justin Balko & Brandie Taylor - VI4 Scientists Doing Things

Dr. Justin Balko and graduate student Brandie Taylor challenged each other to a pipette race while we asked them some questions about their research....... Click to watch!


Dawn Necomb & Nowrin Chowdhury - VI4 Scientists Doing Things

Dawn Necomb & Nowrin Chowdhury - VI4 Scientists Doing Things

Dr. Dawn Newcomb and graduate student Nowrin Chowdhury challenged each other to a game of Uno while we asked them some questions about their research...... Click to watch!

Previous Articles

Interview with Dr. Rob Carnahan

Interview with Dr. Rob Carnahan

We sat down with Dr. Robert Carnahan from the Vanderbilt Vaccine Center to talk about antibody therapeutics and how they can be used in the fight against COVID-19..... Click to watch!


What's in my mRNA Vaccine? Explainer Video. By Taylor Engdahl

What's in my mRNA Vaccine? Explainer Video

The mRNA vaccine is a new type of vaccine that allows your body to trigger an immune response without using the actual germ to train your immune system. Instead, it trains your immune response using a piece of the virus and will later protect you from getting infected/sick if you encounter the actual virus.... Click to watch!


Metabolic Syndrome and COVID-19. By Sohini Roy

Metabolic Syndrome and COVID-19

In the past few months, several observational studies drawing on data from the first wave of COVID-19 infections have highlighted the patient’s pre-existing metabolic syndrome affect the susceptibility to COVID-19, its severity and as well as the course of the disease.... Click to read.


It took a weekend to design a COVID-19 vaccine, and why we might not be prepared next time. By Taylor Engdahl

It took a weekend to design a COVID-19 vaccine,
and why we might not be prepared next time.

On January 11th, 2020, scientists around the globe awoke to the public deposition of the entire genome for the novel coronavirus – later known as SARS-CoV-2. That weekend, researchers at the University of Texas at Austin designed a vaccine based on the SARS-CoV-2 spike protein, which adorns the surface of the virus... Click to read.


SARS-CoV-2 is changing. What does that mean for vaccines and treatments? By Taylor Engdahl

SARS-CoV-2 is changing.
What does that mean for vaccines and treatments?

SARS-CoV-2 is gaining momentum in the evolutionary arms race. The question is: will our vaccines and antibody therapeutics remain effective against emerging variants?... Click to read.


Developing a Vaccine at Pandemic Speed by Chris Hofmann

A COVID-19 Vaccine:
Why We Need It and How We Get There Yesterday

Vaccines are typically developed through a lengthy, rigorous process that averages 10-15 years from inception to approval. The goal is to create a vaccine that is safe and with good immunogenicity, meaning it stimulates a strong immune response, to generate antibodies which can neutralize an invading pathogen... Click to read.


How good is your memory? Debating the duration of COVID-19 immunity by Caroline Cencer

How good is your memory?
Debating the duration of COVID-19 immunity.

So, what can we believe when it comes to COVID-19 and its lasting immunity?...So far results point to an order of 3-6 months...To truly understand what it means to have “lasting immunity”, we need to take a step back and return to the basis of immunological memory... Click to read.


Cancer Vaccines: Are We There Yet? By Sohini Roy, Ph.D.

Cancer Vaccines:
Are We There Yet?

The concept of immunity has intrigued humankind for centuries. From prehistoric times when disease was viewed as a form of punishment for wrong deeds by supernatural forces, to Louis Pasteur’s germ theory of disease, the field of immunology has come a long way.... Click to read.

Interview with Dr. Rob Carnahan

Interview with Dr. Rob Carnahan

We sat down with Dr. Robert Carnahan from the Vanderbilt Vaccine Center to talk about antibody therapeutics and how they can be used in the fight against COVID-19..... Click to watch!


What's in my mRNA Vaccine? Explainer Video. By Taylor Engdahl

What's in my mRNA Vaccine? Explainer Video

The mRNA vaccine is a new type of vaccine that allows your body to trigger an immune response without using the actual germ to train your immune system. Instead, it trains your immune response using a piece of the virus and will later protect you from getting infected/sick if you encounter the actual virus.... Click to watch!


Metabolic Syndrome and COVID-19. By Sohini Roy

Metabolic Syndrome and COVID-19

In the past few months, several observational studies drawing on data from the first wave of COVID-19 infections have highlighted the patient’s pre-existing metabolic syndrome affect the susceptibility to COVID-19, its severity and as well as the course of the disease... Click to read.


It took a weekend to design a COVID-19 vaccine, and why we might not be prepared next time. By Taylor Engdahl

It took a weekend to design a COVID-19 vaccine,
and why we might not be prepared next time.

On January 11th, 2020, scientists around the globe awoke to the public deposition of the entire genome for the novel coronavirus – later known as SARS-CoV-2. That weekend, researchers at the University of Texas at Austin designed a vaccine based on the SARS-CoV-2 spike protein, which adorns the surface of the virus... Click to read.


SARS-CoV-2 is changing. What does that mean for vaccines and treatments? By Taylor Engdahl

SARS-CoV-2 is changing.
What does that mean for vaccines and treatments?

SARS-CoV-2 is gaining momentum in the evolutionary arms race. The question is: will our vaccines and antibody therapeutics remain effective against emerging variants?... Click to read.


Developing a Vaccine at Pandemic Speed by Chris Hofmann

A COVID-19 Vaccine:
Why We Need It and How We Get There Yesterday

Vaccines are typically developed through a lengthy, rigorous process that averages 10-15 years from inception to approval. The goal is to create a vaccine that is safe and with good immunogenicity, meaning it stimulates a strong immune response, to generate antibodies which can neutralize an invading pathogen... Click to read.


How good is your memory? Debating the duration of COVID-19 immunity by Caroline Cencer

How good is your memory?
Debating the duration of COVID-19 immunity.

So, what can we believe when it comes to COVID-19 and its lasting immunity?...So far results point to an order of 3-6 months...To truly understand what it means to have “lasting immunity”, we need to take a step back and return to the basis of immunological memory... Click to read.


Cancer Vaccines: Are We There Yet? By Sohini Roy, Ph.D.

Cancer Vaccines:
Are We There Yet?

The concept of immunity has intrigued humankind for centuries. From prehistoric times when disease was viewed as a form of punishment for wrong deeds by supernatural forces, to Louis Pasteur’s germ theory of disease, the field of immunology has come a long way.... Click to read.